Mizushima, Tohru
Ltd.,
Japan
2025 Rank: 97736
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3635 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97736 | 83581 |
| Total Cites | 8044 | 9865 |
| H-index | 49 | 54 |
| Hm-index | 19 | 22 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 91 | 107 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 492 | 778 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 4244 | 5488 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6453 | 6911 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.43 |
| Self-Citation Percentage |
18.46%
|
|
Mizushima, Tohru
Ltd.,
Japan
2024 Rank: 96038
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3712 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96038 | 79504 |
| Total Cites | 7622 | 9445 |
| H-index | 48 | 53 |
| Hm-index | 19 | 22 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 86 | 102 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 475 | 761 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 4080 | 5322 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6101 | 6558 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.44 |
| Self-Citation Percentage |
19.30%
|
|
Mizushima, Tohru
Ltd.,
Japan
2023 Rank: 92838
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3735 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92838 | 77291 |
| Total Cites | 7175 | 8991 |
| H-index | 47 | 51 |
| Hm-index | 18 | 21 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 81 | 97 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 461 | 747 |
| Number of Single+First+Last Authored Papers | 177 | 177 |
| Total Cites to Single+First+Last Authored Papers | 3883 | 5123 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5718 | 6169 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.46 |
| Self-Citation Percentage |
20.20%
|
|
Mizushima, Tohru
Ltd,
Japan
2022 Rank: 89843
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3795 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89843 | 73168 |
| Total Cites | 6685 | 8477 |
| H-index | 44 | 50 |
| Hm-index | 18 | 21 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 75 | 90 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 450 | 735 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 3633 | 4859 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5320 | 5759 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.47 |
| Self-Citation Percentage |
21.14%
|
|
Mizushima, Tohru
LTT Bio-Pharma Co., Ltd,
Japan
2021 Rank: 90263
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 873 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90263 | 72073 |
| Total Cites | 6415 | 8197 |
| H-index | 43 | 49 |
| Hm-index | 17 | 20 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 72 | 87 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 437 | 722 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 3504 | 4724 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5098 | 5532 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.48 |
| Self-Citation Percentage |
21.74%
|
|
Mizushima, Tohru
LTT Bio-Pharma Co., Ltd,
Japan
2020 Rank: 91495
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 837 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91495 | 69243 |
| Total Cites | 5817 | 7554 |
| H-index | 40 | 48 |
| Hm-index | 16 | 20 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 63 | 78 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 417 | 701 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 3237 | 4434 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4586 | 4986 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.52 |
| Self-Citation Percentage |
22.99%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.